Bioequivalence evaluation of two strengths of risperidone tablet formulations in healthy volunteers

Abstract

This study demonstrated the bioequivalence between the test and the reference product of risperidone of both 1 and 2 mg formulations. Both formulations of each strength may, therefore, be prescribed interchangeably.